CYP21A2 Mutation Analysis in Korean Patients With Congenital Adrenal Hyperplasia Using Complementary Methods: Sequencing After Long-Range PCR and Restriction Fragment Length Polymorphism Analysis With Multiple Ligation-Dependent Probe Amplification Assay
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
CYP21A2 mutation analysis of congenital adrenal hyperplasia (CAH) is challenging because of the genomic presence of a homologous CYP21A2 pseudogene and the significant incidence of pseudogene conversion and large deletions. The objective of this study was to accurately analyze the CYP21A2 genotype in Korean CAH patients using a combination of complementary methods. Long-range PCR and restriction fragment length polymorphism analyses were performed to confirm valid amplification of CYP21A2 and to detect large gene conversions and deletions before direct sequencing. Multiple ligation-dependent probe amplification (MLPA) analysis was conducted concurrently in 14 CAH-suspected patients and six family members of three patients. We identified 27 CYP21A2 mutant alleles in 14 CAH-suspected patients. The c.293-13A>G (or c.293-13C>G) was the most common mutation, and p.Ile173Asn was the second, identified in 25% and 17.9% of alleles, respectively. A novel frame-shift mutation of c.492delA (p.Glu 164Aspfs*24) was detected. Large deletions were detected by MLPA in 10.7% of the alleles. Mutation studies of the six familial members for three of the patients aided in the identification of haplotypes. In summary, we successfully identified CYP21A2 mutations using both long-range PCR and sequencing and dosage analyses. Our data correspond relatively well with the previously reported mutation spectrum analysis.
Abstract
CYP21A2 mutation analysis of congenital adrenal hyperplasia (CAH) is challenging because of the genomic presence of a homologous CYP21A2 pseudogene and the significant incidence of pseudogene conversion and large deletions. The objective of this study was to accurately analyze the CYP21A2 genotype in Korean CAH patients using a combination of complementary methods. Long-range PCR and restriction fragment length polymorphism analyses were performed to confirm valid amplification of CYP21A2 and to detect large gene conversions and deletions before direct sequencing. Multiple ligation-dependent probe amplification (MLPA) analysis was conducted concurrently in 14 CAH-suspected patients and six family members of three patients. We identified 27 CYP21A2 mutant alleles in 14 CAH-suspected patients. The c.293-13A>G (or c.293-13C>G) was the most common mutation, and p.Ile173Asn was the second, identified in 25% and 17.9% of alleles, respectively. A novel frame-shift mutation of c.492delA (p.Glu 164Aspfs*24) was detected. Large deletions were detected by MLPA in 10.7% of the alleles. Mutation studies of the six familial members for three of the patients aided in the identification of haplotypes. In summary, we successfully identified CYP21A2 mutations using both long-range PCR and sequencing and dosage analyses. Our data correspond relatively well with the previously reported mutation spectrum analysis.
참고문헌 (18)
- White PC, "Congenital adrenal hyperplasia due to 21-hydroxylase deficiency", Endocr Rev, 21, pp.245~291 (2000)
- Speiser PW, "Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 95, pp.4133~4160 (2010)
- White PC, "Structure of human steroid 21-hydroxylase genes", Proc Natl Acad Sci U S A, 83, pp.5111~5115 (1986)
- Speiser PW, "Congenital adrenal hyperplasia", N Engl J Med, 349, pp.776~788 (2003)
- Lee HH, "Variants of the CYP21A2 and CYP21A1P genes in congenital adrenal hyperplasia", Clin Chim Acta, 418, pp.37~44 (2013)
- Lee HH, "Comparing the Southern blot method and polymerase chain reaction product analysis for chimeric RCCX detection in CYP21A2 deficiency", Anal Biochem, 399, pp.293~298 (2010)
- Lee HH, "PCR-based detection of the CYP21 deletion and TNXA", TNXB hybrid in the RCCX module, 2004, pp.83, 944~950
- New MI, "Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency", Proc Natl Acad Sci U S A, 110, pp.2611~2616 (2013)
- Krone N, "Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany", J Clin Endocrinol Metab, 85, pp.1059~1065 (2000)
- Lee HH, "Low frequency of the CYP21A2 deletion in ethnic Chinese (Taiwanese) patients with 21-hydroxylase deficiency", Mol Genet Metab, 93, pp.450~457 (2008)
- Wedell A, "Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): implications for diagnosis, prognosis and treatment", Acta Paediatr, 87, pp.159~164 (1998)
- Marino R, "Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia", Clin Endocrinol (Oxf), 75, pp.427~435 (2011)
- Stikkelbroeck NM, "CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations", J Clin Endocrinol Metab, 88, pp.3852~3859 (2003)
- Ma D, "Molecular analysis of the CYP21A2 gene in Chinese patients with steroid 21-hydroxylase deficiency", Clin Biochem, 47, pp.455~463 (2014)
- 유양호, "Genotype-phenotype correlation in 27 pediatric patients in congenital adrenal hyperplasia due to 21-hydroxylase deficiency in a single center", Annals of Pediatirc Endocrinology & Metabolism, 18(3), pp.128~134 (2013), 대한소아내분비학회
- Jang JH, "Multiplex ligation-dependent probe amplification assay for diagnosis of congenital adrenal hyperplasia", Ann Clin Lab Sci, 41, pp.44~47 (2011)
- Choi JH, "Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency", Exp Clin Endocrinol Diabetes, 120, pp.23~27 (2012)
- Xu Z, "Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia", J Mol Diagn, 15, pp.745~753 (2013)